Fluocinonide

LYDERM (fluocinonide) is indicated for topical therapy of corticosteroid responsive acute and chronic skin eruptions where an anti-inflammatory, anti-allergenic and anti-pruritic activity in the topical management is required.

1% is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in patients 12 years of age or older. ( 1 ) Limitation of Use: Treatment beyond 2 consecutive weeks is not recommended and the total dosage should not exceed 60 g per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis.

( 1 ) Avoid use on the face, groin, or axillae. 2 ) Avoid use in perioral dermatitis or rosacea. 4) ]. 1% for longer than 2 weeks has not been established and because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis.

Therapy should be discontinued when control of the disease is achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary. Do not use more than half of the 120 g tube per week. 1% should not be used in the treatment of rosacea or perioral dermatitis, and should not be used on the face, groin, or axillae.

Metosyn is suitable for treating a wide variety of local inflammatory, pruritic and allergic disorders of the skin.

It is indicated in the following conditions:

Eczema and dermatitis: atopic eczema, seborrhoeic dermatitis, discoid eczema, contact dermatitis, neurodermatitis. Prurigo, psoriasis (excluding widespread plaque psoriasis). Lichen planus. Discoid lupus erythematosus. Metosyn Ointment with its emollient effects, is particularly suitable for dry scaly lesions.